The National Institutes of Health has selected Rutgers University as one of the five additional hubs designed to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care and enhance health. The newly selected Research Evaluation and Commercialization Hubs (REACH) expand a national network of proof-of-concept centers that links 34 academic institutions developing best practices to translate biomedical innovations into public benefit.
Recent Posts
- Virtual Trial Shows Combo Rescue Inhaler Nearly Halves Severe Asthma Attacks.
- Scientists Develop Process Using Molecules in the Cell to Identify Environmental Signals.
- Learning Health System Scholars Training Program – 2025 RFA Open Now!
- Tracking Tiny Facial Movements Can Reveal Subtle Emotions in Autistic Individuals.
- AI Ethics Lab Explores Impacts of the Technology’s Rapid Growth.
Categories
- Community (2,253)
- Covid (986)
- CTO Events (6)
- News (2,870)
- Pilots (21)